Table:
begin	end	state
1	5	non-cytoplasmic
6	55	transmembrane
56	62	non-cytoplasmic
63	84	transmembrane
85	111	cytoplasmic
112	137	transmembrane
138	145	non-cytoplasmic
146	164	transmembrane
165	169	cytoplasmic
170	187	transmembrane
188	206	non-cytoplasmic
207	227	transmembrane
228	263	cytoplasmic
264	286	transmembrane
287	323	non-cytoplasmic
324	350	transmembrane
351	362	cytoplasmic
363	386	transmembrane
387	397	non-cytoplasmic
398	416	transmembrane
417	422	cytoplasmic
423	451	transmembrane
452	477	non-cytoplasmic
478	498	transmembrane
499	516	cytoplasmic

Input:
>WP_092347632.1 NCBI__GCF_900107645.1:WP_092347632.1
MWDGMLSGMLTGISTTMIPMNIAMVLFGCFMGSLIGMLPGLGPITAVALMIPVTYGLDPS
SGMVLLAGVYYGAIFGGSTSSILINAPGEAATVATALDGYPLARQGHPGKALAVAAYASF
SGGTISVIMLMIFAPILASVATSFQSADYFALMILGLTAVSAFAGRGGVLKALLMVVLGL
MLATVGTDQTSGVQRFTFGSLELLDGIEFLLLAMATFALTEALSIVLKRDESSDSLKPRT
IGFKNLKVTKSEFKQIAPTIGRSSLLGFIIGVLPGAGATLGSFMAYGMERNLASPEEQKK
FGKGSLRGLAAPEAGNNAASSGSFVPLLCLGIPGSGTTAVMLGALIAYGIEPGPRMLTAN
PQVFWGLIMSMYLGNVFLLILNLPLIPYFARLLAVPRNFMVPMILFFSLMGVYLVTFNDF
DILMMVIFCIAAMALRLMNFPMAPLLLGFILGGLMEDNLRRALLIYNDSFSFMWERPLTL
GINLATLLILVFPMIRSFIARRKGGGKPGNEVVVEV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server